Rationale: Phosphatidylcholine (PC) is the predominant phospholipid component of circulating lipoproteins. The majority of PC is formed by the choline pathway. However, approximately one-third of hepatic PC can also be synthesized by phosphatidylethanolamine N-methyltransferase (PEMT). PEMT is required for normal secretion of very-low-density lipoproteins from the liver. We hypothesized that lack of PEMT would attenuate atherosclerosis and improve myocardial function.
idemia and arterial disease. 1 Elevated plasma levels of low-density lipoproteins (LDLs) and their precursors, verylow-density lipoproteins (VLDLs) are well-established risk factors for cardiovascular disease. 2 The plasma concentrations of VLDL and LDL are determined by their rate of removal from plasma via receptor-mediated endocytosis and lipolysis, as well as by the rate of hepatic VLDL secretion. Generally, research investigating the role of lipoproteins in the progression of atherosclerosis focused on the metabolism of the core lipids triacylglycerol (TG) and cholesteryl ester (CE). 2 However, phospholipids (PLs) are fundamental in the assembly and secretion of VLDLs from the liver. [3] [4] [5] In addition, PLs on the surface of circulating VLDL and LDL come into contact with cell surface enzymes and receptors which affect the rate of lipoprotein removal. 5 Despite the importance of PLs for lipoprotein metabolism, the link between atherosclerosis and PL biosynthesis has only been examined in one study. 5 Furthermore, the link with cardiomyopathy has never been examined.
Phosphatidylcholine (PC) is the predominant PL component of VLDLs and LDLs. 3 PC is synthesized on the hepatic endoplasmic reticulum where nascent lipoproteins are assembled, suggesting that the processes of hepatic PC synthesis and VLDL assembly and secretion may be coupled. The majority of hepatic PC is formed via the choline pathway which is regulated by the activity of CTP:phosphocholine cytidylyltransferase. 3 The liver is a unique tissue because approximately one-third of PC is synthesized by phosphatidylethanolamine N-methyltransferase (PEMT). 3 PEMT cata-lyzes three sequential methylations of phosphatidylethanolamine using S-adenosylmethionine as a methyl donor. 3 A specific requirement for PEMT in VLDL secretion has been demonstrated in vivo and in experiments with hepatocytes. 4 Targeted deletion of the Pemt gene in mice fed a high fat/high cholesterol diet reduced hepatic VLDL secretion (plasma fasted apolipoprotein (apo)B100 and TG levels) by 50%. 4 Mice that lack PEMT and the LDL receptor and fed a high fat/high cholesterol diet are protected from atherosclerosis compared with mice that only lack the receptor. 5 A well-established mouse model of atherosclerosis is the apoE-knockout (apoE-KO) mouse. 6 ApoE is a glycoprotein which functions as a ligand for receptor-mediated lipoprotein removal from the blood. In the absence of apoE, the ability to clear plasma lipoproteins is severely impaired resulting in elevated levels of LDLs and VLDLs. Unlike other mouse models which require high fat or western-type diet to promote plaque formation, apoE-deficient mice develop lesions spontaneously on a chow diet. 6 The time-dependent formation and anatomic localization of these lesions resembles the human disease more closely than in other mouse atherosclerosis models. 6 More recently, it was demonstrated that Ϸ1-yearold apoE-deficient mice develop changes in left-ventricular structure and function as a result of atherosclerotic lesions. 7, 8 Therefore, to study the contribution of PEMT to atherosclerotic lesion formation and cardiac function in a clinically relevant mouse model of human disease, we combined the mouse model of PEMT deficiency with apoE deficiency. 6 These studies established that on a chow diet deletion of PEMT attenuates the development of atherosclerosis and the development of cardiac dysfunction.
Methods

Animal Care
Wild-type mice were C57BL/6J (The Jackson Laboratory, Bar Harbor, ME). Mice with genetic disruption of the Pemt gene were backcrossed for seven generations in a C57BL/6J background strain. Pemt ϩ/ϩ /Apoe Ϫ/Ϫ and Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ were generated by interbreeding Pemt Ϫ/Ϫ mice with Apoe Ϫ/Ϫ mice (C57BL/6J background). All mice used were male and fed a standard chow diet (LabDiet). See the Online Data Supplement, available at http://circres.ahajournals.org.
Lipid and Lipoprotein Analyses
Mice were fasted overnight. Plasma lipoproteins were separated by size using fast-protein liquid chromatography. Lipids were measured by gas-liquid chromatography and phosphorus assay. See the Online Data Supplement.
Tissue Preparation and Histology
Cryosections (10 m) of the proximal aorta were prepared and stained for neutral lipid using Oil Red O. Atherosclerosis was quantified by the en face technique. For Masson's trichrome stain, hearts were fixed and cross-sectioned (5 m). See the Online Data Supplement.
In Vivo Assessment of Cardiac Function and Blood Pressure
Transthoracic echocardiography was performed on mildly anesthetized mice using a Vevo 770 High-Resolution Imaging System equipped with a 30-MHz transducer (RMV-707b; VisualSonics, Toronto, Canada). Noninvasive blood pressure measurements were obtained with a tail cuff system (IITC Corp). Central (aortic) blood pressures were measured from freely moving mice by means of implantable radio-telemetry (DSI, St Paul, MN). See the Online Data Supplement.
Immunoblot Analyses
Cardiac homogenates (50 g protein) or plasma (2 L) were electrophoresed on SDS-polyacrylamide gels. Immunoreactive proteins were detected using the enhanced chemiluminescence system (Amersham Biosciences) according to the instructions of the manufacturer. See the Online Data Supplement.
Statistical Analysis
All data are meansϮSEM. Comparisons between mouse strains were performed using the unpaired Student's 2-tailed t test or 1-way ANOVA using Student-Newman-Keuls post hoc analysis where appropriate. A probability value of Ͻ0.05 was considered significant.
Results
Hepatic Lipid Composition
To determine whether the lack of PEMT in apo E-deficient mice altered hepatic PL composition, we examined the PC and PE content of the livers. There was a small but significant (8%) decrease in hepatic PC levels and an 18% increase in PE content, in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice at 6-months of age compared with Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice ( Figure 1A ). Hepatic PC/PE molar ratios reflect the overall membrane PL composition of the secretory system in which nascent VLDLs are formed. The changes in hepatic PL levels resulted in 22% lower PC/PE molar ratios in livers of Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice compared with Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice ( Figure 1A ). Similarly, the hepatic PC content and the PC/PE ratio were significantly lower (by 12% and 14%, respectively) in 12month-old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice compared with Pemt ϩ/ϩ / Apoe Ϫ/Ϫ mice ( Figure 1B) . These data indicate that PEMT is important for maintaining normal hepatic levels of PC in mice lacking apoE. Livers of 6-and 12-month-old Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ mice contained less hepatic TG (Online Figure I 
PEMT Deficiency in Apoe ؊/؊ Mice Reduces Atherogenic Plasma Lipoproteins
PEMT deficiency has previously been shown to reduce plasma lipid levels. [3] [4] [5] Therefore, we determined if the absence of PEMT reduced plasma lipid content in apoE-KO mice. Analysis of plasma samples from 6-month-old mice revealed an 8% decrease in plasma PC with no difference in PC/PE ratios between Pemt genotypes ( Figure 1C ). However, both the PC level and PC/PE ratio in plasma of 12-month-old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice were significantly lower (by 18% and 11% respectively) than in age-matched Pemt ϩ/ϩ /Apoe Ϫ/Ϫ controls ( Figure 1D ). Pemt ϩ/ϩ /Apoe Ϫ/Ϫ and Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ mice had similar plasma levels of cholesterol and CE after being fed the chow diet for 6 months (Figure 2A ). However, the 6-month-old PEMT-deficient mice had 25% less plasma TG than the age-matched Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice ( Figure 2B ). Furthermore, plasma cholesterol and CE levels were Ϸ24% lower in the 12-month-old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice than in age-matched Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice, and the plasma TG content was reduced by 45% by PEMT deficiency ( Figure 2C and 2D). To determine the number of VLDL/IDL/ LDL particles in the plasma we compared the amount of apoB48 in Pemt ϩ/ϩ /Apoe Ϫ/Ϫ and Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice ( Figure 2E and 2F). The level of apoB100 was similar between genotypes at both time points ( Figure 2E ). However, the absence of PEMT significantly reduced the level of apoB48 in 12-month-old mice ( Figure 2F ).
The plasma lipoproteins were fractionated by gel filtration chromatography and their lipid content was measured. The amount of cholesterol in each lipoprotein fraction was not altered by PEMT deficiency in 6-month-old mice ( Figure  3A ). However, one-year-old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice had less cholesterol in the VLDL/intermediate density lipoprotein (IDL)/LDL fractions ( Figure 3B ) than did the Pemt ϩ/ϩ / Apoe Ϫ/Ϫ animals. The amount of cholesterol in high density lipoproteins was unaltered by the absence of PEMT. As expected, the lower levels of plasma TG in 6-month-old and 12-month-old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ compared with Pemt ϩ/ϩ / Apoe Ϫ/Ϫ mice was attributable to a reduction in VLDL-TG ( Figure 3C and 3D). These data indicate that PEMT deficiency in Apoe Ϫ/Ϫ mice results in an atheroprotective plasma lipoprotein profile.
The Absence of PEMT Decreases the Amount of Aortic Cholesterol in Apoe ؊/؊ Mice
It has been well established that during aging apoE-deficient mice spontaneously develop atherosclerotic lesions when fed a chow diet. 6 To determine whether PEMT deficiency attenuated atherosclerosis in Apoe Ϫ/Ϫ mice, we assessed the development of aortic lesions in 12-month-old mice. The 12-month old animals were chosen because they experienced the largest hypolipidemic effect in the absence of PEMT. In the aortic root, the size of the plaques stained by Oil Red O were smaller in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice than in Pemt ϩ/ϩ / Apoe Ϫ/Ϫ mice ( Figure 4A ). Quantification of lesion area along the entire aorta was determined by en face analysis ( Figure 4B ). The percentage of the aortic surface area covered by atherosclerotic lesions was 28% lower in the Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ mice than in the Pemt ϩ/ϩ /Apoe Ϫ/Ϫ ( Figure 4B ). We also compared aortic cholesterol content between genotypes ( Figure 4C ). This parameter has been previously used as a sensitive and independent parameter for quantification of atherosclerosis in mice because it accounts for lesion thickness which continues to increase when the area available for lesion development has been saturated. 9 Figure 4C shows that the amount of cholesterol and CE in aortas of PEMT-deficient mice was Ϸ40% less than in age-matched Pemt ϩ/ϩ / Apoe Ϫ/Ϫ control mice. Therefore, targeted deletion of PEMT in apoE-deficient mice reduces both the size and cholesterol content of atherosclerotic lesions in the aortic wall.
Pemt ؊/؊ /Apoe ؊/؊ Mice Are Resistant to Age-Dependent Cardiac Dysfunction
The development of atherosclerosis in apoE-KO mice has been shown to contribute to age-dependent aortic stiffening 7, 8, 10 and endothelial dysfunction, 11 The resulting longterm increases in cardiac after-load associated with these pathologies in apoE-deficient mice have been linked to age-dependent cardiac dysfunction. 7, 8, 11, 12 We, therefore, investigated whether PEMT deficiency prevented the consequences of atherosclerosis on aortic and cardiac function in apoE-deficient mice. Pulse wave velocity (PWV) is a direct measure of aortic stiffening associated with vascular dysfunc-tion and plaque formation. 13 Consistent with previous findings, we found that PWV was significantly increased in apoE-KO mice compared with age-matched wild-type mice ( Figure 4D ). 8, 10 However, in the absence of PEMT the PWV remained elevated with levels similar to that of apoE-KO mice, indicating that the modest reduction in atherosclerosis did not improve aortic stiffening. Furthermore, the vascular dysfunction in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ and Pemt ϩ/ϩ /Apoe Ϫ/Ϫ did not result in hypertension as blood pressures remained similar to wild-type values at 10-months of age (Table) .
Though the absence of PEMT did not significantly improve aortic compliance, we identified a significant improvement in both cardiac structure and function. Analysis of cardiac structure by echocardiography indicated that left ventricle internal dimension in systole ( Figure 5A ) and diastole ( Figure 5B ) of 10-month-old apoE-deficient mice was significantly higher than age-matched wild-type mice. Differences were not observed in echocardiographic measurements between genotypes of 6-month-old mice (data not shown). This suggests that Apoe Ϫ/Ϫ mice develop an aging dependent cardiac dilation. Next we determined whether PEMT deficiency prevented the development of cardiac dilation. Indeed, 10-month old Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ had significantly smaller left ventricle internal dimensions in systole and diastole ( Figure 5A and 5B) compared with age matched Apoe Ϫ/Ϫ mice and similar to wild-type animals. These results show that the absence of PEMT prevented age-dependent Figure 5C ). The increased time required to elevate ventricular pressure, a prerequisite for ejection of blood, indicates impaired left ventricular function. Other variables of systolic function including ejection fraction ( Figure 5D ) and fractional shortening ( Figure 5E ) were lower in the apoEdeficient mice compared with Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice. In addition, a lower myocardial performance index in Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ compared with age-matched Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice indicates that PEMT deficiency markedly improved overall systolic and diastolic function ( Figure 5F ). As an early indicator of dilated cardiomyopathy is enlarged atria, 1 a smaller atrial size was also observed in 10-month-old Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ compared with Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice (Table) . Taken together, these results demonstrate that PEMT deficiency prevents the decline of cardiac function normally associated with Apoe Ϫ/Ϫ mice. 7, 8, 12 Cardiac cross-sections of 12-month-old Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice revealed severely increased cardiac fibrosis ( Figure 6A ) that was also evident in the endocardium ( Figure 6C ) which develops as a result of contact with mural thrombi. 14 As mural thrombi are frequently formed when ejection fraction is reduced, this finding is consistent with our echocardiography data for the 10-month-old Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice ( Figure   5D ). Importantly, in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ and wild-type mice cardiac fibrosis was significantly reduced ( Figure 6B ) and endocardial fibrosis was absent ( Figure 6D and 6E) . To further characterize the effects of PEMT deficiency, we also examined other features associated with cardiomyopathy such as fibrosis of the interstitium and myocardial disarray which occurs as thickening myofibers intersect at various angles to produce a whorled appearance. 15 Both interstitial fibrosis and myocardial disarray were observed extensively throughout the left ventricle of Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice (Figure 6F) but not of Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice or wild-type mice ( Figure 6G and 6H) . Finally, the Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice had lower body weight and heart mass compared with Pemt ϩ/ϩ / Apoe Ϫ/Ϫ control animals (Online Table I ). Other physical characteristics were similar (Online Table I ). Therefore, PEMT deficiency prevents the pathological remodelling of the myocardium that contributes to the development of dilated cardiomyopathy in apoE-deficient mice.
Reversal of Myocardial Triacylglycerol Accumulation in Pemt ؊/؊ /Apoe ؊/؊ Mice
Because the absence of PEMT in apoE-KO mice prevents the development of cardiac dysfunction without improving aortic stiffening, we investigated alternative mechanisms to explain the cardioprotective effect of PEMT deficiency. It is accepted that PEMT is a quantitatively significant source of PC only in the liver. 3 Consistent with previous results we were unable to detect PEMT protein in the heart by immunoblot (Online Figure II, A) . This is likely attributable to the extremely low level of PEMT transcript detected in heart at less then 0.0001% of the hepatic PEMT mRNA level (Online Figure II,  B) . Similarly, we were unable to detect a difference in cardiac PC levels in the absence of PEMT ( Figure 7A ). Thus, in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice the cardioprotection is likely attrib-utable to the established effect of PEMT deficiency on lipid levels.
Lipid-induced cardiomyopathy as a result of excess myocardial lipid uptake is characterized by myocardial lipid accumulation, LV chamber dilation, myocardial fibrosis, elevated fatty acid oxidation (FAO) and contractile dysfunction. 16 -21 Because myocardial lipid accumulation is regulated in part by the supply of circulating TG, 21 we investigated whether the hyperlipidemia in apoE-KO mice resulted in cardiac lipid accumulation. Hearts of Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice contained Ϸ2-fold more TG compared with wild-type mice ( Figure 7B ). Remarkably, in the absence of PEMT the level of cardiac TG was reduced to near normal wild-type levels. Compared with apoE-KO animals, PEMT deficiency reduced myocardial TG (34%) to the same extent as plasma VLDL-TG (45%) suggesting a central role for the supply of circulating TG. Changes in plasma nonesterified fatty acids did not contribute to the reduced cardiac steatosis because NEFA levels were similar in Pemt ϩ/ϩ /Apoe Ϫ/Ϫ and Pemt Ϫ/Ϫ / Apoe Ϫ/Ϫ mice (Online Figure III, A) . Other lipids which accumulated in the heart of apoE-KO mice were not reduced in the absence of PEMT including cholesterol, CE and ceramide ( Figure 7C and 7D ). Long-chain acyl-coenzyme (Co)A did not accumulate in the heart of apoE-KO mice ( Figure 7E) .
To determine whether excessive FAO contributed to cardiac lipotoxicity in apoE-KO mice we measured malonyl-CoA levels. In Pemt ϩ/ϩ /Apoe Ϫ/Ϫ mice the malonyl-CoA levels were decreased indicating elevated FAO compared with mice lacking PEMT ( Figure 7F ). Consistent with this finding the mRNAs for peroxisome-proliferator activated receptor-␣ (PPAR␣) targets, acyl-CoA oxidase, fatty acid transport protein 1, and carnitine palmitoyl-transferase-␤ which promote FAO are elevated in cardiac tissue of apoE-KO mice (Online Figure IV, A) . Elevated FAO contributes to cardiac dysfunction in part through generation of reactive oxygen species which cause mitochondrial structural damage. 22 However, an increase in reactive oxygen species did not occur as determined by normal levels of the lipid peroxidation byproduct 4-hydroxy-2-nonenal (Online Figure  III, B) . 23 Furthermore, proteins which control mitochondrial biogenesis and function 24 (PPAR␥ coactivator-1␣, ATP synthase-5␤, uncoupling protein 3) were similarly expressed between genotypes indicating normal mitochondrial metabolism (Online Figure IV, A and B) . Thus, the cardiomyopathy in apoE-KO mice is not accompanied by FAO-induced oxidative stress or mitochondrial dysfunction. Together, our data indicate that PEMT deficiency was protective against excess cardiac lipid accumulation that contributes to the development of cardiomyopathy in apoE-KO mice.
Discussion
Atherosclerosis and heart failure are major clinical problems that result in a significant proportion of the morbidity and mortality of aging populations. 2, 13, 25 Our data provide evidence that disruption of the Pemt gene in 1-year-old apoEdeficient mice fed a chow diet reduces atherosclerotic lesions by Ϸ30% and prevents the development of a lipotoxic cardiomyopathy. These beneficial effects are attributable to the hypolipidemic effect of PEMT deficiency.
Development of Atherosclerosis Does Not Contribute to Cardiac Dysfunction in ApoE-KO Mice
The apoE-deficient mouse represents a well-characterized model of atherosclerosis that has been linked to agedependent changes in cardiac structure and function. 8, 10 Therefore, we used mice with an apoE-null background to study the role of PEMT in the age-dependent progression of cardiovascular disease. Consistent with the well-established hypolipidemic effect of PEMT deficiency, [3] [4] [5] we observed significant decreases in plasma VLDL-TG and LDL-cholesterol levels in the Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ animals. This alteration in lipid metabolism likely confers cardioprotection against the age-dependent lesion formation and cardiac dysfunction that occurs in 10-month-old apoE null mice.
We determined that 10-month-old apoE-deficient mice clearly exhibited physical, functional and histological markers of dilated cardiomyopathy including increased internal dimension of the left ventricular chamber, decreased ejection fraction, and greater left ventricular fibrosis ( Figures 6 and  7) . 1, 15 Based on the well-established associations between atherosclerosis and vascular stiffening, 13 previous studies using Apoe Ϫ/Ϫ mice have linked the development of atherosclerosis to cardiac dysfunction. 8, 10 One effect of elevated arterial resistance is the development of systemic hypertension. However, systemic hypertension is unlikely to be a major contributor to cardiac dysfunction in 10-month-old Apoe Ϫ/Ϫ mice because their blood pressure is within the normal range. 8, 10, 11 Yang et al 11 previously showed that aging Apoe Ϫ/Ϫ mice develop high systemic blood pressure but this was not observed in several more recent publications. 8, 10 A chronic increase in aortic stiffness has also been proposed to explain the development of cardiac dysfunction in Apoe Ϫ/Ϫ mice. 7, 8, 10 Because atherosclerotic plaques significantly increase aortic stiffness in various animal models of cardiovascular disease, including the apoE-deficient mice, 8, 10 we determined that in vivo aortic stiffness, was significantly elevated in Apoe Ϫ/Ϫ mice compared with wild-type animals ( Figure 4D ). However, we were unable to detect an elevation in systolic aortic (central) pressures (Table) . Furthermore, the absence of PEMT attenuated the development of the agedependent cardiac dysfunction in Apoe Ϫ/Ϫ mice despite similar aortic stiffness and central blood pressures. Together, these data indicated that the Apoe Ϫ/Ϫ mouse model does not develop age-dependent cardiac dysfunction because of a chronic increase in arterial resistance.
PEMT Deficiency Prevents the Development of Lipotoxic Cardiomyopathy
We have demonstrated for the first time that 10-month-old Apoe Ϫ/Ϫ mice develop a lipotoxic cardiomyopathy attributable to the characteristic myocardial lipid accumulation. It is becoming clear that the accumulation of intramyocardial lipid metabolites is caused by a mismatch between fatty acid (FA) supply and the ability of the heart to upregulate metabolism. In a number of mouse models, lipotoxic cardiomyopathy results when excessive FA supply exceeds elevated FAO. [17] [18] [19] Similarly, in Apoe Ϫ/Ϫ mice intramyocardial TG continues to accumulate despite increased FAO, indicating a primary role for the excessive amounts of circulating VLDL-TG and NEFA. It is accepted that increased plasma levels of VLDL-TG and NEFA contribute to elevated intramyocardial TG contents. 21, 26 In parallel with decreased VLDL-TG, intramyocardial TG was reduced in the absence of PEMT likely reflecting a better match between FA supply and utilization. PEMT protein expression is below the level of detection in the heart and its absence does not decrease cardiac PC levels (Figure 7) . Thus, in Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ mice the cardioprotection is likely attributable to the observed effect of PEMT deficiency on plasma lipid levels.
Because a variety of different lipids have been shown to accumulate in genetic mouse models of lipotoxic cardiomyopathy, it remains unclear which lipids are primarily responsible for the toxic effects. One widely held view is that excess TG is causal. 21 This is supported by the correlation of contractile dysfunction with myocardial TG content 16,18 -20,27 and that reduced TG is associated with improved cardiac function. 20 Consistent, with this theory the contractile dysfunction in apoE deficient animals is accompanied by elevated cardiac TG, and reversed in the Pemt Ϫ/Ϫ /Apoe Ϫ/Ϫ animals with lower TG levels. Other potentially toxic lipids that accumulated in the hearts of apoE null mouse were not reduced when PEMT was absent suggesting that they are not the predominant pathological species in the Apoe Ϫ/Ϫ model. Currently, the toxic effect of TG in the heart is yet to be fully elucidated and may be direct or by providing a substrate pool for generating additional detrimental lipid species. 21 The latter is particularly intriguing because the cardiac TG pool can be turned over rapidly 28 and may contribute to the metabolic fate of fatty acids. 29 Our data does not support the proposed protective role of cardiac TG which stores toxic lipid metabolites. 30 The apparent contradiction between studies may be attributable to our limited knowledge of how TG synthesis, hydrolysis and turnover are regulated in the heart. Clearly, our data demonstrates that cardiac dysfunction in mice lacking apoE is greatly exacerbated when TG accumulates in the myocardium.
The hypolipidemic effect of PEMT deficiency has now been identified in 2 well-established but inherently different mouse models of atherosclerosis. The apoE-KO mouse accumulates cholesterol in apoB48 containing VLDL-sized particles which is dissimilar to the smaller apoB100 containing LDL-sized particles in LDLr-KO mice. 6 The beneficial effect of PEMT deficiency on both backgrounds firmly establishes PEMT as an individual contributor to the pathology of atherosclerosis and as a relevant drug target for treating hyperlipidemia in humans. PEMT deficiency decreased cholesterol levels in LDLr-KO mice more dramatically (Ϸ70%) 5 than in apoE-KO mice (Ϸ24%) indicating that apoB100 containing LDL may be particularly susceptible to PLmediated reduction. Because Ϸ75% of cholesterol is carried on LDL in humans, 2 the majority of hyperlipidemic patients should benefit from therapies which inhibit PEMT.
In conclusion, PEMT deficiency in apoE-deficient mice (1) reduces TG and cholesterol levels in circulation and in the heart; (2) reduces age-associated atherosclerosis; and (3) attenuates the development of lipotoxic cardiomyopathy. We suggest that inhibition of PEMT activity may prove to be a novel therapeutic target for treatment of atherosclerosis and cardiac dysfunction.
